RENAL-ALLOGRAFT REJECTION - FUNCTIONAL IMPAIRMENT OF KIDNEY EPITHELIAL-CELL MONOLAYERS MEDIATED BY LYMPHOKINE-ACTIVATED KILLER-CELLS AND BY ANTIBODY

被引:7
|
作者
KIRBY, JA
MORGAN, JC
SHENTON, BK
LENNARD, TWJ
PROUD, G
TAYLOR, RMR
机构
[1] Department of Surgery, Medical School, Newcastle upon Tyne
基金
英国惠康基金;
关键词
D O I
10.1097/00007890-199104000-00030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A continuous line of human kidney epithelial cells was cultured to confluency on porous membranes, and the formation of intercellular tight junctions was monitored by measuring increases in the trans-monolayer electrical resistance. Typical monolayers developed functioning tight junctions within 4 days of culture and showed an increase in resistance of 1840 +/- 440 ohms (mean +/- SD; n = 5) at this time. Conventional Cr-21 release assays showed that suspended kidney cells were lysed by specific antibody and complement but were relatively resistant to lysis mediated by lymphokine-activated killer cells. However, when antibody and complement or LAK cells were added to functioning kidney cell monolayers the electrical resistance of the monolayers was rapidly reduced in both cases. In the absence of trans-monolayer resistance the ion gradients essential for renal tubular function will not be supported. These results indicate that the ability of a cytotoxic effector cell to liberate Cr-51 from suspended kidney cells may not be a sensitive assay for the ability of these effector cells to impair the function of structured kidney cell monolayers. It is possible that significant kidney dysfunction may occur during renal allograft rejection by failure of trans-epithelium resistance in the absence of widespread epithelial cell lysis.
引用
收藏
页码:891 / 895
页数:5
相关论文
共 50 条
  • [1] RENAL-ALLOGRAFT REJECTION - POSSIBLE INVOLVEMENT OF LYMPHOKINE-ACTIVATED KILLER CELLS
    KIRBY, JA
    FORSYTHE, JLR
    PROUD, G
    TAYLOR, RMR
    IMMUNOLOGY, 1989, 67 (01) : 62 - 67
  • [2] RENAL-ALLOGRAFT REJECTION - PROTECTION OF RENAL TUBULAR EPITHELIAL-CELLS FROM LYMPHOKINE ACTIVATED KILLER-CELL MEDIATED LYSIS BY PRETREATMENT WITH CYTOKINES
    KIRBY, JA
    FORSYTHE, JLR
    SIMM, A
    PROUD, G
    TAYLOR, RMR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (09) : 824 - 828
  • [3] MONOCLONAL-ANTIBODY TARGETING OF LYMPHOKINE-ACTIVATED KILLER-CELLS FOR THE TREATMENT OF HUMAN MALIGNANCIES
    HONSIK, CJ
    REISFELD, RA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 139 - 139
  • [4] LYMPHOKINE-ACTIVATED KILLER TRAFFIC ASSAY AND OUR PRELIMINARY CLINICAL-RESULTS OF REGIONAL ARTERIAL INFUSION OF LYMPHOKINE-ACTIVATED KILLER-CELLS FOR RENAL-CELL CARCINOMA
    HAYAKAWA, M
    KOYAMA, Y
    WILLIAMS, RD
    OSAWA, A
    UROLOGIA INTERNATIONALIS, 1991, 47 : 127 - 131
  • [5] A COMMON TARGET-CELL ANTIGEN RECOGNIZED BY LYMPHOKINE-ACTIVATED KILLER-CELLS
    LINKER, JB
    BANKHURST, AD
    CLINICAL RESEARCH, 1986, 34 (01): : A100 - A100
  • [6] CELL-CYCLE ASSESSMENT OF ADOPTIVE TRANSFERRED LYMPHOKINE-ACTIVATED KILLER-CELLS
    WATANABE, R
    TANAKA, N
    NAOMOTO, Y
    MOREIRA, LF
    ORITA, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1994, 24 (02) : 59 - 65
  • [7] MORPHOLOGIC AND FUNCTIONAL-CHARACTERIZATION OF PERFORIN-DEFICIENT LYMPHOKINE-ACTIVATED KILLER-CELLS
    LIU, CC
    WALSH, CM
    ETO, N
    CLARK, WR
    YOUNG, JDE
    JOURNAL OF IMMUNOLOGY, 1995, 155 (02): : 602 - 608
  • [8] COMBINATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN TREATING METASTATIC RENAL-CELL CARCINOMA
    FUJIOKA, T
    NOMURA, K
    HASEGAWA, M
    ISHIKURA, K
    KUBO, T
    BRITISH JOURNAL OF UROLOGY, 1994, 73 (01): : 23 - 31
  • [9] DEPRESSED ABILITY OF PATIENTS WITH MELANOMA OR RENAL-CELL CARCINOMA TO GENERATE ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS
    SEDLMAYR, P
    RABINOWICH, H
    ELDER, EM
    ERNSTOFF, MS
    KIRKWOOD, JM
    HERBERMAN, RB
    WHITESIDE, TL
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (05): : 336 - 346
  • [10] EFFECTOR FUNCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND CYTOTOXIC LYMPHOCYTES-T IN OVARIAN EPITHELIAL CARCINOMA
    LENTZ, SS
    KOVACH, JS
    MCKEAN, DJ
    WIEAND, HS
    PODRATZ, KC
    GYNECOLOGIC ONCOLOGY, 1990, 38 (02) : 191 - 196